Collaboration, License and Other Arrangements (Tables)

12 Months Ended

Dec. 31, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Allocation of Consideration Assets Acquired and Liabilities Assumed

The total cash paid to acquire Alpine, allocation of consideration to the assets acquired and liabilities assumed and

AIPR&D was as follows:

	(in millions)
Cash consideration to acquire Alpine’s outstanding common stock	$4,536.9
Cash consideration for Alpine’s vested and unvested equity awards	420.6
Total cash consideration paid to Alpine	4,957.5
Less: Expense related to unvested equity awards	(197.6)
Transaction costs	40.7
Total consideration allocated	$4,800.6
Cash and cash equivalents	$31.9
Current marketable securities	209.5
Long-term marketable securities	48.5
Deferred tax asset	105.5
Total other assets	19.5
Total liabilities	(37.5)
Total identifiable assets acquired, net	377.4
Acquired in-process research and development expense	4,423.2
Total consideration allocated	$4,800.6